-34A randomized pilot phase I study of modified CEA peptide...A randomized pilot phase I study of modified CEA peptide (CAP1_6D)&

病毒，包括白血病和神经系统疾病。FDA在一份声明中说，Avioq公司的HTLV-I/II Microelisa系统是现在唯一可以用来筛选献血中两类人类T淋巴细胞...HTLV病毒检测，为血液机构提供更大的灵活性并且有助于保证血液供应的安全。”HTLV-I和HTLV-II的都可以通过输血，注射器，受感染的母亲

主办单位：中国人民大学卫生医药发展中心 学分：国家级 I 类学分 6 分 一、培训内容 1、临床路径制定与实施及效果评价；2、临床路径管理的实现策略...中国医院协会评价评估部主任 四、会议费用 会费 1280 元/人 (含国家级 I 类继续医学教育学分 6 分、资料等)，6 人免 1 人培训费，食宿统一安排

CT冠状面重建图像-56CT冠状面重建图像-62CT冠状面重建图像-58...早期胃癌I型-22正常胃CT MRP-10正常胃壁-8

DN控制血糖的益处-52DN控制血压的益处-56DN血糖控制的要点-53... III-41低蛋白饮食开同改善脂代谢紊乱-50低蛋白饮食减慢肾衰进展I-39低蛋白饮食开同

由江苏省肿瘤医院、江苏省抗癌协会肿瘤标志专委会、江苏省生物化学与分子生物学会主办的「第九届肿瘤标志物临床应用与研究进展会议」定于 2018 年 7 月 13～15 日在南京举行。国家级 I 类继续医学教育学分 10 分 [项目编号：2018-11-00-355 (国) ]。本次会议的主题是肿瘤标志物临床应用与研究进展

；(2)适用于包括I临床试验在内的科学研究的研究标准。后者纳入了基于影像技术及脑脊液检查的生物标志物的应用。并根据所出现的牛物标志物的性质。将最终MCI诊断的确

毒副作用，并且周围性神经病的发生率较低。这个I/II实验的目的是明确CMP的最大耐受剂量（MTD），以评价在刚刚确诊的大于65岁的多发性骨髓瘤患者中使用该治疗方案的安全性和有效性。方法：在I期实验，Cfz是唯一剂量变化的药物，最小剂量为20 mg/m2（第一水平），最大预计剂量为36 mg/m2(第三

由广州军区广州总医院主办的“第五期全国经口寰枢椎复位内固定（TARP）技术暨颈椎前后路内固定技术学习班”，定于2014年5月16日-18日在广州军区广州总医院举行。为国家级、全军级和广东省级继续医学教育项目，将授予I类学分证书（8分）。本期学习班将介绍和推广广州军区广州总医院

级继续教育I类学分10分。崇明岛是世界最大的河口冲积岛，是中国第三大岛，面积1200平方公里。环境优美，气候宜人，为国家级生态岛，每年吸引大量游客

分子流行病学再揭示人类复杂疾病遗传因素及其与环境因素相互作用发挥重要作用,为人类疾病的风险评估、预防和个性化治疗提供依据。全基因组关联分析（GWAS）为全面系统研究复杂疾病的遗传因素掀开了新的一页，为我们了解人类复杂疾病的发病机制提供了更多的线索。科学家已经在肥胖、糖尿病、冠心病、阿尔茨海默、乳腺癌、前列腺癌、肺癌、胃癌等一系列复杂疾病中进行了全基因组关联研究并找到疾病相关的易感基因，我国科学家也在银屑病、精神病和冠心病等方面开展了GWAS研究并取得成效。国家科技部最新公布了“常见重大疾病全基因组关联分析和药物基因组学研究”的863重点项目，吹响了我国大规模开展GWAS研究的号角。为了让更多的相关研究人员，特别是广大研究生了解GWAS的研究原理和方法，学会设计GWAS的研究和分析实验结果，同时在癌症领域分享海内外研究专家们的成功经验，并期待在GWAS方面进行交流合作,复旦大学和美国Van Andel 研究所将于2009年7月12-14日在上海联合举办上海分子流行病学与GWAS国际 研讨会, 期待各位同道免费参加，请有意者及时将回执返回联系邮箱。免注册费（食宿餐饮费用自理）。名额有限，报名从速！时间： 2009年7月12－14日
报到地点： 复旦大学卿云楼宾馆 上海市邯郸路220号，200433
会议地点： 复旦大学逸夫楼报告厅
联 系 人： 赵雪莹 高歌 联系电话： 021-55664495
回执邮箱： GWAS2009@gmail.com
BackgroundRecent success of genome-wide association studies (GWAS) in the U.S. and Europe has lead to the identification of a large number of genetic variants that are associated with disease risk and progression, including those for cancer and cardiovascular diseases. The discovery of these genetic markers not only improves our understanding of disease etiology, but also contributes significantly to risk prediction, early detection, and targeted treatment of diseases.Although GWAS have been used in Chinese populations to identify Chinese-specific risk-associated genetic variants for several common diseases such as breast cancer and psoriasis, many more GWAS are needed for various diseases. A better understanding of the importance of GWAS and a better knowledge of study design and data analysis of GWAS will further promote broad application of GWAS in China. This symposium which will cover genetic epidemiology and GWAS in China is organized to serve this purpose. We have invited a group of experts in this area from the U.S. and China to share their experience in GWAS, and we hope to foster an environment which will encourage an open discussion among all participants.
Objectives• To better understand the potential applications of GWAS
• To address practical issues in study design, implementation, and data analysis of GWAS
• To promote interaction and collaboration among researchers who are interested in GWAS
• To explore other important studies after GWAS: gene-environment interaction, risk prediction, and functional analyses
• To consider issues and implications related to genomic and personalize medicine
Organizing committeeThe organizing committee consists of four members:
Dr. Jianfeng Xu (Co-Chair)
Dr. Daru Lu (Co-Chair)
Dr. Li Jin (Co-Chair ,Advisor)
Dr. Qingyi Wei (Co-Chair, Advisor)
PresentationsSession I: Genetic epidemiology and GWAS of cancer
• Breast cancer in Chinese populations Xiao-ou Shu
• Genetic association studies of skin cancer Jiali Han
• Genetic variants in the MC1R gene and risk of cutaneous melanoma Qingyi Wei
• Genetic association studies of lung cancer in Chinese populations Daru Lu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao Zhou
• Molecular epidemiology of stomach cancer Weimin YeSession II: Genetic epidemiology and GWAS of other diseases
• Genetic association studies of hypertension in Chinese populations Jiang He
• GWAS of Autoimmune Diseases (Psoriasis, etc.) in Chinese populations Wei Huang
• Molecular epidemiology of diabetes in Chinese populations Weiping Jia
• Molecular genetics study of hypertension in Chinese populations Dingliang Zhu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao ZhouSession III: Post-GWAS studies
• Genetic structure of Chinese population Li Jin
• High-throughput genotyping for GWAS and fine mapping studies Siqun Lilly Zheng
• Molecular genetics study of neural tube defect Hongyan Wang
• Risk prediction using genetic variants in prostate cancer Jianfeng Xu
• Gene-environmental interaction in smoking related cancer Zuo-Feng Zhang
• Cancer Somatic Genomics Bin TehSession IV: Short presentations by participants and discussion
Registration时　　间： 2009年7月12－14日
报到地点： 复旦大学卿云楼宾馆大厅 上海市邯郸路220号 (200433)
会议地点： 复旦大学逸夫楼报告厅
联 系 人： 赵雪莹，高歌 (Shanghai, China)；Tamara Adams (U.S.)
联系电话： 21-55664495 (Shanghai, China)；336-713-7532 (U.S.)
回执邮箱： GWAS2009@gmail.com (Shanghai, China)；tsadams@wfubmc.edu (U.S.)
Invited speakers (alphabetic)• Jiali Han, Ph.D., is an Assistant Professor of Medicine at Harvard Medical School. His major research areas are:
• Genetic epidemiology of skin cancer and breast cancer
• Genome-wide association studies
• Gene-environment interaction• Jiang He, M.D. Ph.D., is a Professor and Chair of Epidemiology, Tulane University School of Public Health., U.S.A. His major research areas are:
• Genetic epidemiology of hypertension
• Gene-nutrition interaction of cardiovascular disease• Wei Huang, Ph.D., is a Professor and Executive Deputy Director of Chinese National Human Genome Center at Shanghai, China. Her major research areas are:
• Genetic susceptibility to autoimmune diseases, cardiovascular diseases and cancer.
• Genome-wide association studies
• Genetic variants and association study• Weiping Jia M.D., is a professor of endocrinology at Shanghai Institute of Diabetes, Shanghai No.6 People’s Hospital, Shanghai Jiaotong University, Her major research area is:
• Molecular endocrinology and diabetes• Li Jin, Ph.D, is a Professor of Genetics and vice President of Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolism diseases
• Genetic markers for population genetics• Daru Lu, Ph.D, is a Professor of Genetics and Vice Dean of School of Life Sciences, Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolic disease• Xiao-ou Shu, M.D, Ph,D, is a Professor of Medicine in the Department of Medicine at the Vanderbilt University School of Medicine, U.S.A. Her major research areas are:
• Genetic and lifestyle predictors of cancer and other chronic diseases
• Cohort study methodology
• Incorporating biomarkers in risk prediction• Bin Teh, M.D, is a Distinguished Scientific Investigator at Van Andel Institute, U.S.A. His major research areas are:
• Translational cancer research
• Gene expression profiling
• Cancer genome high-throughput sequencing• Hongyan Wang, Ph.D, is a professor of genetics at School of Life sciences, Fudan University, China. Her major research area is:
• Molecular genetics and epidemiology of birth defects (deformity of neural tube, congenital heart disease, etc.)• Qingyi Wei, M.D, Ph.D, is a Professor of Epidemiology at The University of Texas M. D. Anderson Cancer Center, U.S.A. His major research areas are:
• Molecular epidemiology of DNA repair, apoptosis, and skin cancer and head and neck cancer
• Genetic susceptibility to cancer
• DNA repair and apoptosis phenotype markers• Jianfeng Xu, M.D, Dr.PH, is a Professor of Epidemiology and Cancer Biology and Director of the Center for Cancer Genomics at Wake Forest University School of Medicine, U.S.A. His major research areas are:
• Genetic epidemiology of prostate cancer
• Genome-wide association and fine mapping analysis
• Risk prediction using genetic markers and other clinicopathologic variables• Zuo-Feng Zhang, M.D., Ph.D, is a Professor of Epidemiology at UCLA School of Public Health, U.S.A. His major research areas are:
• Molecular epidemiology of smoking-related cancers
• Confirmation studies of SNPs identified in genome-wide association studies in smoking-related cancers
• Gene-environmental interaction between genetic markers and environmental factors• S. Lilly Zheng, M.D, is a Professor of Medicine and Director of the Genotyping Laboratory at Wake Forest University School of Medicine. U.S.A. Her major research areas are:
• High-throughput genotyping and sequencing
• Genetic epidemiology of prostate cancer• Gangqiao Zhou, Ph.D, is a Professor of Medical Genetics and Genomics in National Academy of Military Medical Science. His major research area is:
• molecular and genetics of complex diseases• Dingliang Zhu, M.D, is a professor of cardiology at Shanghai Institute of Hypertension, Shanghai, China. His major research area is:
• Molecular and genetics of cardiovascular diseases• Weimin Ye, Ph.D, is a Professor of Medical Epidemiology at Karolinska Institutet, Sweden. His major research areas are: Etiology of upper gastrointestinal diseases
• Topic of presentation: Molecular epidemiology of stomach cancer

血液科病房分设 2 个病区共 56 张床位，其中包括百级层流病房 (移植舱)6 间，普通床位 50 张。宽敞明亮的普通病房移植病房

本期微访谈，丁香园特别邀请上海同济大学附属同济医院普外科施宝民主任与广大站友一起探讨“ 胰腺肿瘤切除，扩大还是缩小？——保留脏器功能的胰腺肿瘤局部切除术”这一话题。微访谈提问地址：http://i.dxy.cn/talk/pancreas胰腺肿瘤是一种

《ChineseJournalofCancer》（《癌症》杂志，以下简称CJC）于10月12日正式入驻丁香客（官方主页：http://i.dxy.cn/cjc）。CJC是由中华人民共和国教育部主管，中山医科大学肿瘤防治中心(世界卫生组织癌症研究合作中心)主办，美国

过敏症状已经对孩子造成了影响，需要及时就诊。过敏季节，注意预防现在依然是过敏季节，家长也要注意帮助孩子加强预防。以下这些措施都能帮助孩子减轻过敏症状。○ 尽量减少户外活动，以室内活动为主，关闭窗户，使用空调进行换气，开净化器。○ 在外出时，一定要戴口罩。○ 外出归来时，可以帮助和指导孩子用海盐水清洗鼻腔，通过

和墙壁除了拳头还有更多的空间，就很可能是出现了骨盆前倾。这三类人容易骨盆前倾○ 长期伏案工作者：长时间坐姿使髂腰肌长期处于被动缩短状态，坐位时骨盆通常被牵拉至前倾位。○ 缺乏锻炼者：身体背侧肌肉、臀肌较弱，不能很好地把骨盆维持在中立位，进而转化为下交叉综合症。○ 经常穿高跟鞋的女性。改善

或肌肉病变所需的更多信息。如果有以下情况，可能会接受肌电图检查：○存在肢体麻木、感觉异常或者疼痛○出现肌肉萎缩○出现